<DOC>
	<DOCNO>NCT00827190</DOCNO>
	<brief_summary>This first-in-human study ILS-920 . This study provide initial assessment safety , tolerability , pharmacokinetics ( PK ) , pharmacodynamics ( PD ) ILS-920 administration ascend single intravenous ( IV ) dose healthy adult subject .</brief_summary>
	<brief_title>Study Evaluating Single Ascending Doses Of ILS-920</brief_title>
	<detailed_description />
	<criteria>Men woman nonchildbearing potential Aged 18 50 year inclusive screening . Any significant cardiovascular , hepatic , renal , respiratory , gastrointestinal , endocrine , immunologic , dermatologic , hematologic , neurologic , psychiatric disease . History drug abuse within 1 year study day 1 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Acute Ischemic Stroke</keyword>
</DOC>